Elanco Animal Health Q4 Adjusted EPS $0.08 Misses $0.11 Estimate, Sales $1.03B Beat $1.00B Estimate
Portfolio Pulse from Benzinga Newsdesk
Elanco Animal Health (NYSE:ELAN) reported Q4 adjusted EPS of $0.08, missing the $0.11 estimate, a 57.89% decrease from last year. Sales were $1.03B, beating the $1.00B estimate, a 5.08% increase from last year.
February 26, 2024 | 11:30 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Elanco Animal Health reported a Q4 adjusted EPS of $0.08, missing estimates, with a 57.89% decrease from last year. However, sales increased to $1.03B, exceeding expectations.
The missed EPS estimate and significant decrease in earnings from the previous year could negatively impact investor sentiment towards ELAN. However, the beat on sales estimates and year-over-year sales growth may offset some of the negative impact, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100